← Eichor
Study identifier: NCT06920940 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Child Bipolar Network Ketogenic Diet Approach to Bipolar Disorder in Adolescents

Condition: Bipolar Disorder (BD) · Bipolar Disorder NOS · Bipolar Disorder I or II  ·  Sponsor: University of California, Los Angeles

PhaseNA
Planned participants80
Who can joinAll sexes, 12 Years to 21 Years
Healthy volunteersNo

About this study

The present study is an open trial of ketogenic diets for adolescents and young adults (ages 12-21 yrs) in the depressive or mixed phases of bipolar disorder (BD). The investigators aim to determine whether combining standard of care pharmacological treatment for bipolar spectrum disorders with a 16-week ketogenic diet is well-tolerated and associated with improvements in depression, inflammatory and metabolic indicators, and executive functioning over the study period. The experimental treatment in this study is a 16-week full ketogenic diet. Four study sites (UCLA, U Cincinnati, U Colorado and U Pittsburgh) will recruit 80 total youth (20 each) from bipolar specialty clinics. All youth eligible for the ketogenic therapy will be provided with the ketogenic diet and standard of care pharmacological treatment. During the diet therapy youth will be seen by a study child/adolescent psychiatrist at least once a month (and more frequently when needed), with the psychiatrist recommending and providing side effects monitoring and pharmacotherapy as clinically indicated. The youth and caregivers will also meet with an expert dietitian who will coach all youth on maintaining the ketogenic diet (low carbs, high fats, medium protein) and making sure the child is tolerating the diet and getting enough liquid and nutrients, following the practice guidelines of the International Ketogenic Diet Study Group for treating youth. All youth and involved caregivers will also be provided will at…

This description comes directly from the study's public registry record.

Talk to the study team

David J Miklowitz, Ph.D.  ·  310-267-2659  ·  dmiklowitz@mednet.ucla.edu

Danielle M Denenny, Ph.D.  ·  310-825-8740  ·  ddenenny@mednet.ucla.edu

Always discuss trial participation with your own doctor first.

Locations (4)

UCLA Semel Institute Max Gray Child and Adolescent Mood Disorders Program (CHAMP)Los Angeles, California, United StatesRecruiting
University of Colorado Denver, Anschutz Medical CampusAurora, Colorado, United StatesNot Yet Recruiting
University of Cincinnati College of MedicineCincinnati, Ohio, United StatesRecruiting
University of Pittsburgh School of MedicinePittsburgh, Pennsylvania, United StatesNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06920940